64Cu-SarTate
N/A
Report date: 2026/01/04 11:31:59
NME
Base Information
Drug Name64Cu-SarTate
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of MelbourneClarity Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesClarity Pharmaceuticals Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A